- Also known as
- MOTS-c · MOTSc · Mitochondrial ORF of the 12S rRNA type-c
- Class
- Mitochondrial-derived peptide
- Form
- Lyophilised powder, 10 mg and 40 mg vials
- Sizes
- 10 mg · 40 mg
- Storage, dry
- −20 °C, dry and dark
- Storage, mixed
- 2–8 °C, use within 28 days of mixing (as generally reported for reconstituted peptides)
- BAC water per size
- 10 mg: 2 mL · 40 mg: 3 mL
What is MOTS-C?
By chemistry MOTS-C falls under mitochondrial-derived peptide. Research published on it covers rat, mouse and cell culture. Several spellings in the literature point to the same material, among them MOTS-c, MOTSc and Mitochondrial ORF of the 12S rRNA type-c. Its recorded sequence is 16 residues, encoded within the mitochondrial 12S rRNA gene (MRWQEMGYIFYPRKLR). It has been given to people in one study, which was not controlled, so those findings cannot tease the compound apart from everything else that shifted at the same time. We keep it as lyophilised powder in 10 mg and 40 mg vials; it is research material and nothing more. It is not a medicine and is not for use in humans or animals.
What the research shows
| Study | Model | Dose used | Duration | Finding |
|---|---|---|---|---|
| Lin C et al.2024 · Gut · PMID 37788894 | Human observational cohort (85 healthy subjects, 404 HBV patients) plus HBV-infected mice and cells | Not stated in the abstract | Not stated in the abstract | MOTS-c levels correlated negatively with HBV DNA (R = −0.71). In mice and cells MOTS-c inhibited HBV replication by 50–70% with improved liver function and no notable toxicity, and promoted mitochondrial biogenesis and MAVS signalling. |
| Lee C et al.2015 · Cell Metab · PMID 25738459 | Mouse, high-fat diet and ageing models; cell work | Not stated in the abstract | Not stated in the abstract | The paper that named MOTS-c. Its primary target appeared to be skeletal muscle, where it inhibited the folate cycle and de novo purine biosynthesis and activated AMPK; MOTS-c treatment in mice prevented age-dependent and high-fat-diet-induced insulin resistance and diet-induced obesity. |
| Kim KH et al.2018 · Cell Metab · PMID 29983246 | Cell culture (metabolic stress models) | Not stated in the abstract | Not stated in the abstract | Under metabolic stress MOTS-c translocated to the nucleus in an AMPK-dependent manner and regulated a broad range of genes in response to glucose restriction, including antioxidant response element genes, and interacted with NRF2. |
| Li X et al.2025 · Redox Biol · PMID 40403491 | Rat, lung ischaemia-reperfusion injury model; human cardiopulmonary bypass patients (serum levels) | Not stated in the abstract | Serum measured within 24 h after bypass | Exogenous MOTS-c in rats reduced oxidative damage, inflammation, lung injury and mortality. In patients, the rise in serum MOTS-c within 24 h of bypass predicted ARDS (multivariate model AUC 0.885). |
| Yin Y et al.2024 · Adv Sci (Weinh) · PMID 39321430 | Ovarian cancer cell lines and mouse xenograft; patient serum and tumour tissue | Not stated in the abstract | Not stated in the abstract | MOTS-c levels were lower in serum and tumour tissue from ovarian cancer patients. Exogenous MOTS-c inhibited ovarian cancer cell proliferation, migration and invasion and showed an anti-tumour effect in vivo without systemic toxicity, by promoting LARS1 degradation. |
| Li K et al.2025 · Free Radic Biol Med · PMID 41043625 | Chondrocytes (LPS-induced) and mouse osteoarthritis model | Not stated in the abstract | Not stated in the abstract | MOTS-c improved mitochondrial dysfunction and reduced chondrocyte pyroptosis via the Nrf2/TXNIP/NLRP3 axis, and on imaging and histology delayed cartilage degeneration in the mouse model. |
| Wu J et al.2023 · Acta Biochim Biophys Sin (Shanghai) · PMID 36786072 | LPS-induced septic cardiomyopathy model (species not stated in the abstract) | Not stated in the abstract | Not stated in the abstract | MOTS-c reduced inflammatory cytokine mRNA in cardiomyocytes, lowered circulating CK-MB and TnT, and reduced cardiomyocyte apoptosis; the AMPK inhibitor compound C abolished these effects. |
What these studies don't show: What human work there is remains uncontrolled: pilot studies, case reports and retrospective reviews. With nothing to compare against, cause cannot be told apart from coincidence. Small participant numbers and short follow-up leave long-term safety untouched. Purity data confirms what the vial holds and says nothing about whether a compound works.
Every study links to its PubMed record. See all MOTS-C studies in the research library →
MOTS-C price in Canada: 10mg and 40mg vials
Buy MOTS-C in Canada in 2 vial sizes and a starter kit. Prices are in Canadian dollars, you pay by Interac e-Transfer or bank transfer, and orders are shipped from Canadian stock.
| Size | Price | Per mg |
|---|---|---|
| 10 mg | $42.00 | $4.20/mg |
| 40 mg | $70.50 | $1.76/mg |
Starter kit
Is MOTS-C available in Canada?
Canada has no authorized MOTS-C product, because no DIN has been issued for it. No regulator here has reviewed its safety, efficacy or quality. We treat it as laboratory research material and nothing more, not for use in a person or an animal. How Health Canada treats research peptides →
Side effects reported in studies
A small study finding no effect is not proof of safety. Every statement is bound to the study that reported it. None of the cited abstracts records a tolerability finding for MOTS-C. Read more →
Doses used in studies
MOTS-C FAQ
What is MOTS-C?
By chemistry MOTS-C falls under mitochondrial-derived peptide. The research published on it covers rat, mouse and cell culture. Borealis Peptides keeps it as lyophilised powder in 10 mg and 40 mg vials for in-vitro laboratory research. It holds no medicinal authorization and is not for use in any living subject. The table on this page sets out each study, its model and its reported result.
Where can I buy MOTS-C in Canada?
Borealis Peptides dispatches MOTS-C from Canadian stock to research and business addresses within Canada, kept in 10 mg and 40 mg vials. HPLC testing covers every batch, and the certificate identifies the batch in your vial. Only laboratory-research orders are accepted.
Is MOTS-C legal in Canada?
Canada has no authorized MOTS-C product, because no DIN has been issued for it. No regulator here has reviewed its safety, efficacy or quality. We keep it on the shelf as laboratory research material, not for any use in a person or an animal. Because Health Canada has stated that "Research Use Only" labelling does not make a product legal to use in a person, we read it as the purpose the material is stocked for, not an approval to use it.
How much MOTS-C should I use?
We do not field dosing questions. MOTS-C is not supplied for use in a person or an animal, so there is no dose to describe. What this page carries is the quantity each cited study used and the model it was used in, reproduced as the authors published it.
What human evidence is there for MOTS-C?
Human work exists, but none of it is controlled. One study involved people, in the form of pilots, case reports or retrospective reviews. Lacking a control group, these cannot show that the compound caused what was seen, and the page states as much beside the table.
How is MOTS-C stored?
While sealed, hold it at −20 °C in the dark. Solutions sit at 2–8 °C. As a dry powder it travels at room temperature and goes cold on arrival. Light and repeated warming do more harm than the trip itself. Every batch undergoes HPLC testing and the certificate identifies the batch in your vial.
How is the purity of MOTS-C confirmed?
Identity and purity are verified by HPLC for each batch, not once for the whole product. The certificate names the batch it covers, and that batch number is printed on the vial, so a result can be traced back to the exact material behind it. Quote your order number and we will send it.
How does MOTS-C compare with SS-31 and NAD+?
These are distinct compounds with distinct published records, and this site does not rank them. SS-31 and NAD+ carry 7 cited studies and 8 cited studies on their page against 7 here. The useful comparison lies between the two study tables and the models behind them.







